These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 10191779)
1. Thromboplastins, heparin, and polybrene. Carroll WE Am J Clin Pathol; 1999 Apr; 111(4):565. PubMed ID: 10191779 [No Abstract] [Full Text] [Related]
2. The risks of heparin-neutralizing substances. Tripodi A Am J Clin Pathol; 1999 Apr; 111(4):566. PubMed ID: 10191780 [No Abstract] [Full Text] [Related]
3. Thromboplastins, heparin, and polybrene. Carroll WE Am J Clin Pathol; 1996 Oct; 106(4):556. PubMed ID: 8853047 [No Abstract] [Full Text] [Related]
4. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive. Tientadakul P; Kongkan C; Chinswangwatanakul W Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503 [TBL] [Abstract][Full Text] [Related]
5. Further studies on hexadimethrine bromide (polybrene)--an antiheparin agent. KIMURA ET; YOUNG PR; EBERT DM Toxicol Appl Pharmacol; 1959 Nov; 1():560-75. PubMed ID: 14409111 [No Abstract] [Full Text] [Related]
6. Influence of heparin, protamine and polybrene on the time integral of thrombin generation (endogenous thrombin potential). Rotteveel RC; Roozendaal KJ; Weijers RN; Eijsman L Haemostasis; 1996; 26(1):1-10. PubMed ID: 8698272 [TBL] [Abstract][Full Text] [Related]
7. The neutralization of heparin with polybrene. HOHF R; PRESTON FW; TRIPPEL O Q Bull Northwest Univ Med Sch; 1956; 30(2):138-43. PubMed ID: 13359634 [No Abstract] [Full Text] [Related]
8. A comparison of two heparin-neutralizing agents: protamine and polybrene. GODAL HC Scand J Clin Lab Invest; 1960; 12(4):446-57. PubMed ID: 13706163 [No Abstract] [Full Text] [Related]
9. The circulatory effects of hexadimethrine bromide (Polybrene) in dogs. MACKENZIE GJ; WADE JD; DAVIES SH; ZELLOS S Am Heart J; 1961 Oct; 62():511-8. PubMed ID: 14467954 [No Abstract] [Full Text] [Related]
10. THE ANTICOAGULANT ACTION OF POLYBRENE. ZIPURSKY A; WODZICKI AM; RUSSET JI; ISRAELS ED; ISRAELS LG Can J Physiol Pharmacol; 1965 Mar; 43():289-97. PubMed ID: 14329336 [No Abstract] [Full Text] [Related]
11. Heparin neutralization with polybrene administered intravenously. WEISS WA; GILMAN JS; CATENACCI AJ; OSTERBERG AE J Am Med Assoc; 1958 Feb; 166(6):603-7. PubMed ID: 13502035 [No Abstract] [Full Text] [Related]
12. [Clinical experimental study of polybrene for heparin neutralization]. SHIMIZU H; YOSHITA S; TATAMURA S; KAWAAI S; OMOMOTO H; TSUDA H; MORIMOTO S; ONO I Rinsho Geka; 1962 Feb; 17():97-104. PubMed ID: 13911960 [No Abstract] [Full Text] [Related]
13. [Results of the use of a new drug antagonist toward heparin (polybrene) in open heart surgery]. TUCCI G; TOMAI F; NOVELLI GP Ann Ital Chir; 1961 Mar; 38():272-83. PubMed ID: 13778521 [No Abstract] [Full Text] [Related]
14. The nature of the anticoagulant effect of heparin, protamine, polybrene and toluidine blue. OLLENDORFF P Scand J Clin Lab Invest; 1962; 14():267-76. PubMed ID: 14481859 [No Abstract] [Full Text] [Related]
16. Difference in the heparin-neutralizing effect of protamine and polybrene as tested by thrombotest. NORDOY A Scand J Clin Lab Invest; 1963; 15():205-10. PubMed ID: 13938906 [No Abstract] [Full Text] [Related]